Overview

Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an anti-inflammatory drug, called infliximab, will reduce inflammation in the synovial lining in patients with an early stage of osteoarthritis of the knee. It will also help determine if the study medication decreases the accumulation of synovial fluid and prevents cartilage breakdown.
Phase:
Phase 4
Details
Lead Sponsor:
Herbert Lindsley, MD
University of Kansas
Collaborator:
Centocor, Inc.
Treatments:
Infliximab
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate